Details

Autor(en) / Beteiligte

• Pourrajab, Behnaz
• Naderi, Nasim
• Janani, Leila
• Mofid, Vahid
• Hajahmadi, Marjan
• Dehnad, Afsaneh
• Shidfar, Farzad

Titel

Comparison of probiotic yogurt and ordinary yogurt consumption on serum Pentraxin3, NT-proBNP, oxLDL, and ApoB100 in patients with chronic heart failure: a randomized, triple-blind, controlled trial

Ist Teil von

• Food & function, 2020-11, Vol.11 (11), p.1-11

Ort / Verlag

Cambridge: Royal Society of Chemistry

Erscheinungsjahr

2020

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Background and aims : Nowadays, the potential beneficial effects of probiotic yogurt as a functional food has raised much interest. Thus, the aim of this study was to compare the probiotic yogurt and ordinary yogurt consumption on some indices in patients with chronic heart failure (CHF). Methods and results : In this randomized, triple-blind clinical trial, 90 patients with CHF were randomly allocated into two groups to take either probiotic yogurt or ordinary yogurt for 10 weeks. The serum levels of pentraxin3 (PTX3), N-terminal pro-brain natriuretic peptide (NT-proBNP), oxidized low density lipoprotein (oxLDL), and apolipoprotein B100 (ApoB100) were measured at the baseline and at the end of week 10. P -Value <0.05 was defined as statistically significant. Final analyses were performed on 78 patients. The levels of PTX3 and oxLDL in both the groups decreased significantly after 10 weeks, and these reductions were greater in the probiotic group, where the difference between the groups was statistically significant for oxLDL ( P -value: 0.051, adjusted P -value: 0.010) but not significant for PTX3 ( P -value: 0.956, adjusted P -value: 0.236). The changes in the serum NT-proBNP levels were not statistically significant between the groups ( P -value: 0.948, adjusted P -value: 0.306). ApoB100 significantly decreased in the control group compared to the probiotic group and the difference between the groups was significant at first but was not significant after adjusting for the confounders ( P -value: 0.004, adjusted P -value: 0.280). Conclusion : The serum oxLDL significantly reduced due to probiotic yogurt consumption after 10 weeks compared to ordinary yogurt; thus, it may be useful for improving the oxidative status of CHF patients. The clinical trial registry number is IRCT20091114002709N48 ( https://www.irct.ir/IRCT20091114002709N48 , registered 12 March 2018). Nowadays, the potential beneficial effects of probiotic yogurt as a functional food has raised much interest.